Related Experiment Video
Updated: Jan 12, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Advances in Cervical Cancer.
Olivia W Foley1, Danielle Strom2, Emily M Hinchcliff1
1Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Prentice Women's Hospital, 250 E Superior Street Floor 5, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Prentice Women's Hospital, 250 E Superior Street Floor 4, Chicago, IL 60611, USA.
Recent advances in cervical cancer treatment, including immunotherapy for metastatic and recurrent cases, offer improved outcomes and reduced morbidity. These new therapeutic modalities are changing the standard of care for this widespread disease.
Area of Science:
- Gynecologic Oncology
- Medical Oncology
- Immunotherapy
Background:
- Cervical cancer remains a significant global health challenge.
- Limited treatment options and poor prognosis historically characterized advanced stages.
- Recent years have seen substantial progress in therapeutic strategies.
Purpose of the Study:
- To highlight recent advancements in cervical cancer treatment.
- To discuss the impact of immunotherapy on patient care.
- To review improvements in oncologic outcomes and morbidity.
Main Methods:
- Review of recent clinical trials and therapeutic developments.
- Analysis of immunotherapy's role in metastatic and recurrent cervical cancer.
- Evaluation of changes in the standard of care.
Main Results:
- Significant advances have been made across all stages and therapeutic modalities.
- Immunotherapy has been introduced as a novel treatment option.
- These advances promise improved oncologic outcomes and decreased morbidity.
Conclusions:
- The introduction of immunotherapy has transformed the standard of care for advanced cervical cancer.
- Ongoing therapeutic advancements offer hope for better patient prognoses.
- Further research continues to refine treatment strategies for cervical cancer.
More Related Videos
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
06:57Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis